T3 Pharmaceuticals AG closes its second financing round

T3 Pharmaceuticals AG, a Basel-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by Boehringer Ingelheim Venture Fund (BIVF) and Reference Capital SA.

VISCHER acts as legal advisor to T3 Pharmaceuticals AG in the financing round. The team includes Christian Wyss (Partner, Corporate / M&A), Moritz Jäggy (Associate, Corporate / M&A), Francesca Pesenti (Associate, Corporate / M&A), and Pauline Pfirter (Associate, Corporate / M&A).

Christian Wyss

Attorney at Law

• Partner

• +41 58 211 33 39
• [email protected]

Moritz Jäggy

Attorney at Law

• Partner

• +41 58 211 32 33
• [email protected]

Francesca Pesenti

Attorney at Law and Civil Law Notary (BS/BL)

• Managing Associate

• +41 58 211 39 81
• [email protected]

Pauline Pfirter

Attorney at Law

• Managing Associate

• +41 58 211 33 25
• [email protected]